Harnessing lymphoma epigenetics to improve therapies

Area of Science:

• Immunology and Cancer Biology
• Epigenetics and Transcriptional Regulation

Background:

• B-cell development involves complex transcriptional programs regulated by epigenetic modifications.
• Germinal center reactions are crucial for B-cell maturation, involving interactions with T follicular helper cells and follicular dendritic cells.
• Genetic alterations in B-cell lymphomas disrupt these normal epigenetic and transcriptional processes.

Purpose of the Study:

• To review recent studies on follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL).
• To understand how genetic alterations perturb epigenetic and transcriptional programs in B-cell development and immune interactions.
• To identify potential therapeutic targets using epigenetic modifying agents.

Main Methods:

• Review and synthesis of recently published studies on FL and DLBCL.
• Analysis of genetic alterations impacting transcription factors and chromatin modifiers.
• Contextualization within existing knowledge of B-cell development and germinal center reactions.

Main Results:

• Genetic alterations in lymphoma hijack normal B-cell epigenetic programs.
• These alterations skew B-cell differentiation towards the tumor cell-of-origin.
• Altered interactions between lymphoma B-cells and the microenvironment are observed.

Conclusions:

• Understanding the perturbation of epigenetic and transcriptional programs is key to B-cell lymphoma pathogenesis.
• Insights gained inform potential rational therapeutic interventions targeting these aberrant programs.
• Epigenetic modifying agents represent a promising avenue for treating FL and DLBCL.